Medical devices, healthcare technology and the business of care
510(k) clearance · K263598

VasQ

Laminate Medical Technologies · Decision date Oct 29, 2026

MEDTECHLEDGER EXPLANATIONK263598

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for K263598, trade name VasQ, on October 29, 2026, with the submission received September 30, 2026. The applicant is Laminate Medical Technologies of Tel Aviv, Israel; the regulation is 21 CFR 870.4600, Class II, product code QVQ, and the review panel and medical specialty are Cardiovascular. SESE is a 510(k) clearance, not a premarket approval.

The summary describes VasQ as a nitinol extravascular support implanted over an end-to-side upper extremity arteriovenous fistula anastomosis, supplied in five models covering artery and vein diameters of 2 mm to 6 mm. The change from the predicate VasQ (DEN220026, K240119) is removal of the smallest model, model 1, with corresponding revision of the model selection tool and implantation chart and minor labeling updates. The summary states no new performance testing was performed and prior testing was relied on; no independent clinical outcome data appear in the provided documents.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 29, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263598
Regulatory pathway
510(k) premarket notification
Product code
QVQ
Decision code
SESE
Decision date
Oct 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Extravascular Support For An Arteriovenous Fistula For Vascular Access.

Product code
QVQ
FDA device class
2

FDA decision timeline

  1. K263598 received

    Application receipt date recorded by FDA.

  2. K263598 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Laminate Medical Technologies

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Tel Aviv

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records